challenges with bringing novel immune therapies to mds
Published 1 year ago • 57 plays • Length 0:53Download video MP4
Download video MP3
Similar videos
-
2:10
using the innate immune system to treat mds & the value of novel immunotherapies
-
1:34
managing adverse events with novel therapies in lower-risk mds
-
2:43
novel therapies in the future of mds treatment
-
3:22
advances and unanswered questions in aml: novel agents, mrd assessment, and immunotherapy
-
1:41
novel therapies for high-risk mds
-
1:34
challenges associated with transplantation in patients with mpns
-
2:10
challenges in treating patients with hl who relapse after autosct & novel therapies being explored
-
1:45
deciding which patients with mpns are suitable candidates for interferon-based therapy
-
1:35
challenges with diagnosing mds and future outlooks
-
1:54
navigating regulatory challenges in developing and approving therapies for rare lymphomas
-
1:59
topics of interest in mds: the role of maintenance therapy, immune checkpoints & ven-aza in hr-mds
-
1:17
exciting novel treatments being developed for mds
-
2:38
a total approach to mds and unanswered questions in the field
-
1:21
the remnant study: will treating patients at mrd relapse improve survival outcomes?
-
3:01
challenges in distinguishing between pre-mds states and mds, and approaches to improve diagnosis
-
1:38
novel treatment options for lr-mds and the importance of clinical trials in this space
-
1:04
the challenge of treating hma-refractory mds patients
-
2:33
novel immunotherapies in aml and insights into the future of the treatment landscape
-
1:45
overcoming on-target, off-tumor toxicity in aml: current challenges and potential solutions